Terazosin Repurposing Study in ALS (TRUST)
Terazosin RepUrposing STudy in ALS (TRUST) is a single-centre, open-label, biomarker-led proof-of-concept study, funded by the My Name’5 Doddie Foundation, to assess the neuroprotective effects of terazosin in patients with ALS.
Recruitment is now complete. Results will be available in early 2025.